⭐ Recognized by FeedSpot: #12 Best Anesthesiology Blog Worldwide

Uncategorized Published - 3 June, 2020    By - Dr Clemens
Clinical Trials of Neuraxial, Intravenous, and Inhalational Anesthesia for External Cephalic Version

AUTHORS: Hao, Qingzhong MD, PhD et al Anesthesia & Analgesia: April 2020 BACKGROUND: External cephalic version (ECV) is a frequently performed obstetric procedure for fetal breech presentation to avoid cesarean delivery. Neuraxial, intravenous, and inhalational anesthetic techniques have been studied to reduce maternal discomfort caused by the forceful manipulation. This study compares the effects of […]

Read More
Uncategorized Published - 3 June, 2020    By - Dr Clemens
Thromboelastographic Assessment of Fibrinolytic Activity in Postpartum Hemorrhage

AUTHORS: Arnolds, David E. MD, PhD et al *; Scavone, Barbara M. MD*,† Anesthesia & Analgesia: April 2020 BACKGROUND: Postpartum hemorrhage is a leading cause of maternal mortality. Antifibrinolytic therapy has the potential to influence outcomes in postpartum hemorrhage, but the incidence of elevated fibrinolytic activity in postpartum hemorrhage is unknown. METHODS: We retrospectively reviewed […]

Read More
Uncategorized Published - 3 June, 2020    By - Dr Clemens
How the COVID-19 pandemic is traumatizing health care professionals

Author: Rebecca Elia MD KevinMD.com Many of us (especially psychiatrists and physician coaches) have been warning the medical profession at large for weeks now that we are headed for unprecedented numbers of physicians, nurses, other health care workers, and first responders suffering from PTSD. A free support group of psychiatrists for physicians formed rapidly. Several […]

Read More
Uncategorized Published - 3 June, 2020    By - Dr Clemens
Adding to the Tool Chest: Virtual Visits for Chronic Pain

Author: Tony Mira F1rst News                                                                        Summary Pain practitioners are in a unique position to utilize the new waivers and changes […]

Read More
Uncategorized Published - 3 June, 2020    By - Dr Clemens
U.S. awards new $628 million contract to boost output of potential COVID-19 vaccine

Author: Vishwadha Chander Reuters The U.S. government on Monday entered into a $628 million contract with drugmaker Emergent BioSolutions (EBS.N) to boost manufacturing capacity for a potential COVID-19 vaccine. As drugmakers race to develop vaccines, tests and therapies for the disease, the United States is looking to secure manufacturing capacity under its “Operation Warp Speed” […]

Read More